We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$329B
AUM Growth
+$18.7B
Cap. Flow
+$4.79B
Cap. Flow %
1.46%
Top 10 Hldgs %
17.35%
Holding
3,654
New
108
Increased
2,088
Reduced
988
Closed
104

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.91B
2
UPS icon
United Parcel Service
UPS
+$1.86B
3
CVX icon
Chevron
CVX
+$1.72B
4
BX icon
Blackstone
BX
+$904M
5
F icon
Ford
F
+$722M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$1.64B
2
PRU icon
Prudential Financial
PRU
+$553M
3
GPC icon
Genuine Parts
GPC
+$543M
4
CMI icon
Cummins
CMI
+$538M
5
HIG icon
Hartford Financial Services
HIG
+$376M

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Healthcare 13.03%
3 Financials 11.86%
4 Consumer Discretionary 9.84%
5 Industrials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
3076
DELISTED
Esperion Therapeutics
ESPR
$318K ﹤0.01%
199,811
+2,859
+1% +$14.8K
MPX
3077
DELISTED
Marine Products Corp
MPX
$317K ﹤0.01%
24,040
– –
XLF icon
3078
State Street Financial Select Sector SPDR ETF
XLF
$57.9B
$317K ﹤0.01%
9,851
+2,710
+38% +$94.2K
GSG icon
3079
iShares S&P GSCI Commodity-Indexed Trust
GSG
$971M
$315K ﹤0.01%
15,676
-7,473
-32% -$152K
ATLC icon
3080
Atlanticus Holdings
ATLC
$1.65B
$315K ﹤0.01%
11,613
– –
RLYB icon
3081
Rallybio
RLYB
$84.6M
$312K ﹤0.01%
6,832
+1,022
+18% +$52.8K
UFI icon
3082
UNIFI
UFI
$119M
$310K ﹤0.01%
37,965
– –
TIL icon
3083
Instil Bio
TIL
$48.9M
$309K ﹤0.01%
23,343
+1,102
+5% +$16.3K
BIRD icon
3084
Smartbird Inc
BIRD
$19.9M
$308K ﹤0.01%
12,847
– –
NGVC icon
3085
Vitamin Cottage Natural Grocers
NGVC
$766M
$308K ﹤0.01%
26,210
+1,344
+5% +$13.9K
PDYN icon
3086
Palladyne AI
PDYN
$265M
$307K ﹤0.01%
107,789
+5,318
+5% +$18.6K
REAL icon
3087
The RealReal
REAL
$1.51B
$306K ﹤0.01%
243,113
– –
VIGI icon
3088
Vanguard International Dividend Appreciation ETF
VIGI
$9.1B
$299K ﹤0.01%
4,063
-422
-9% -$30.5K
WHWK
3089
Whitehawk Therapeutics
WHWK
$195M
$298K ﹤0.01%
41,219
– –
BBVA icon
3090
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
$297K ﹤0.01%
42,187
+16,493
+64% +$117K
NODK icon
3091
NI Holdings
NODK
$315M
$297K ﹤0.01%
22,856
– –
CTV
3092
DELISTED
Innovid Corp.
CTV
$296K ﹤0.01%
210,020
– –
VTWO icon
3093
Vanguard Russell 2000 ETF
VTWO
$17.6B
$295K ﹤0.01%
4,094
-24,015
-85% -$1.78M
ANTX icon
3094
AN2 Therapeutics
ANTX
$200M
$295K ﹤0.01%
29,898
+5,000
+20% +$55.6K
STLA icon
3095
Stellantis
STLA
$21.3B
$295K ﹤0.01%
+16,222
New +$271K
MHH icon
3096
Mastech Digital
MHH
$94.5M
$292K ﹤0.01%
23,684
– –
USCB icon
3097
USCB Financial Holdings
USCB
$417M
$291K ﹤0.01%
29,405
-925
-3% -$11.1K
CMRX
3098
DELISTED
Chimerix, Inc.
CMRX
$290K ﹤0.01%
229,784
– –
PBFS icon
3099
Pioneer Bancorp
PBFS
$439M
$288K ﹤0.01%
29,251
-3,631
-11% -$39.9K
EGIO
3100
DELISTED
Edgio, Inc. Common Stock
EGIO
$284K ﹤0.01%
8,988
– –
122 123
124
125 126

Similar funds

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab's Q1 2023 Portfolio in Review

As of Q1 2023, Charles Schwab held 3,654 positions worth $329B, up 6% from $310B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q1 2023 filing shows 108 new, 2,088 increased, 988 reduced and 104 closed positions. Its largest new stake was GE HealthCare: 1,875,333 shares worth $154M. The largest sale was IBM, an estimated $1.64B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q1 2023 buy was GE HealthCare: 1,875,333 shares worth $154M.
  • Charles Schwab added most to AbbVie in Q1 2023, an estimated $1.91B increase.
  • Charles Schwab's biggest Q1 2023 reduction was IBM, cutting an estimated $1.64B.
  • Charles Schwab fully exited STORE Capital Corporation in Q1 2023, selling an estimated $100M.
  • Charles Schwab's ten largest holdings make up 17% of its $329B portfolio in Q1 2023.
  • Charles Schwab opened 108 new positions and closed 104 in Q1 2023.
  • Charles Schwab's portfolio value rose 6% quarter-over-quarter to $329B.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.